Among 11 analysts covering Etsy (NASDAQ:ETSY), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. Etsy had 25 analyst reports since October 2, 2018 according to SRatingsIntel. The company was maintained on Monday, March 11 by Morgan Stanley. The firm earned “Hold” rating on Tuesday, February 26 by Morgan Stanley. The stock of Etsy, Inc. (NASDAQ:ETSY) has “Overweight” rating given on Tuesday, October 2 by KeyBanc Capital Markets. The rating was maintained by DA Davidson with “Buy” on Tuesday, February 26. The stock has “Equal-Weight” rating by Morgan Stanley on Wednesday, October 24. As per Tuesday, February 26, the company rating was maintained by Wedbush. KeyBanc Capital Markets maintained the stock with “Overweight” rating in Tuesday, February 26 report. On Tuesday, February 26 the stock rating was maintained by RBC Capital Markets with “Hold”. BTIG Research maintained it with “Buy” rating and $67 target in Tuesday, February 26 report. Deutsche Bank maintained it with “Buy” rating and $74 target in Friday, March 8 report. See Etsy, Inc. (NASDAQ:ETSY) latest ratings:
12/03/2019 Broker: IFS Securities Rating: Inc 80
11/03/2019 Broker: Morgan Stanley Rating: Hold New Target: $65 Maintain
08/03/2019 Broker: Deutsche Bank Rating: Buy New Target: $74 Maintain
08/03/2019 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $75 New Target: $90 Maintain
07/03/2019 Broker: Roth Capital Rating: Buy New Target: $72 Maintain
07/03/2019 Broker: Stifel Nicolaus Rating: Hold New Target: $58 Maintain
08/03/2019 Broker: BTIG Research Old Rating: Buy New Rating: Neutral Downgrade
05/03/2019 Broker: KeyBanc Capital Markets Rating: Buy New Target: $75 Maintain
01/03/2019 Broker: BidaskScore Rating: Buy Upgrade
26/02/2019 Broker: Morgan Stanley Rating: Hold New Target: $49 Maintain
The stock of InflaRx N.V. (NASDAQ:IFRX) is a huge mover today! The stock decreased 2.10% or $1.02 during the last trading session, reaching $47.6. About 202,805 shares traded or 77.72% up from the average. InflaRx N.V. (NASDAQ:IFRX) has risen 39.39% since March 15, 2018 and is uptrending. It has outperformed by 35.02% the S&P500. Some Historical IFRX News: 08/05/2018 – INFLARX N.V. REPORTS CLOSING OF PRIMARY, SECONDARY OFFERING; 08/03/2018 InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 17/05/2018 – InflaRx 1Q Loss/Shr EUR0.04; 29/03/2018 – InflaRx Full Year 2017 Financial & Operating Results; 08/03/2018 – lnflaRx announces first patient enrolled in Phase llb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 08/03/2018 – INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE llB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA; 29/03/2018 – lnflaRx Full Year 2017 Financial & Operating Results; 17/05/2018 – INFLARX NV – CASH POSITION APPROXIMATELY US$137 MLN (EUR 115 MLN) AS OF MARCH 31, 2018; 29/03/2018 – InflaRx FY Loss/Shr EUR2.6; 08/05/2018 – InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common ShrsThe move comes after 7 months negative chart setup for the $1.22 billion company. It was reported on Mar, 15 by Barchart.com. We have $44.27 PT which if reached, will make NASDAQ:IFRX worth $85.54 million less.
Analysts await InflaRx N.V. (NASDAQ:IFRX) to report earnings on April, 4. After $-0.31 actual earnings per share reported by InflaRx N.V. for the previous quarter, Wall Street now forecasts 41.94% negative EPS growth.
More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: Globenewswire.com which released: “Richard Brudnick to Join InflaRx Board of Directors – GlobeNewswire” on February 14, 2019, also Nasdaq.com with their article: “Hydrogenics Reports Fourth Quarter and Full Year 2018 Results – Nasdaq” published on March 15, 2019, Nasdaq.com published: “BCE Hits 52-Week High: What’s Driving the Outperformance? – Nasdaq” on March 14, 2019. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: Nasdaq.com and their article: “NoHo Partners Plc considers issuance of a hybrid bond primarily for the purpose of financing its international and domestic expansion – Nasdaq” published on March 15, 2019 as well as Nasdaq.com‘s news article titled: “Turquoise Hill announces financial results and review of operations for 2018 – Nasdaq” with publication date: March 14, 2019.
InflaRx GmbH, a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology in the United States. The company has market cap of $1.22 billion. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The firm is involved developing IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and other chronic/autoimmune diseases, as well as IFX-2 for the treatment of chronic inflammation and autoimmune diseases.
The stock increased 1.26% or $0.88 during the last trading session, reaching $70.79. About 1.39 million shares traded. Etsy, Inc. (NASDAQ:ETSY) has risen 172.47% since March 15, 2018 and is uptrending. It has outperformed by 168.10% the S&P500. Some Historical ETSY News: 19/03/2018 – Etsy is a buy after proving it can stave off Amazon: @JimCramer; 29/03/2018 – IGNORE: ETSY NAMES EDITH COOPER TO BOARD REPORTED MARCH 28; 08/05/2018 – Etsy Swings to Profit — Earnings Review; 08/03/2018 – ETSY INC ETSY.O – NOTES WILL MATURE ON MARCH 1, 2023, UNLESS EARLIER CONVERTED OR REPURCHASED; 08/05/2018 – ETSY INC ETSY.O FY2018 REV VIEW $539.9 MLN — THOMSON REUTERS l/B/E/S; 08/05/2018 – ETSY 1Q REV. $120.9M, EST. $119.6M; 29/03/2018 – Etsy: With Briggs and Wednesday’s Appointee Edith Cooper, Board Has Expanded to 8 Members; 15/05/2018 – TIGER GLOBAL MANAGEMENT DISSOLVES STAKE IN ETSY – SEC FILING; 21/05/2018 – Free Agents: On the Market: Veterans of Etsy, Chariot, Lyft; 19/03/2018 – Cramer: Etsy is a buy after proving it can stave off Amazon
More notable recent Etsy, Inc. (NASDAQ:ETSY) news were published by: Nasdaq.com which released: “IWM, ETSY, TTD, FIVE: Large Outflows Detected at ETF – Nasdaq” on March 15, 2019, also Finance.Yahoo.com with their article: “ETSY Stock Slides, Then Recovers, Following Investor Day Update – Yahoo Finance” published on March 08, 2019, Benzinga.com published: “Morgan Stanley Is Watching Etsy’s Traction, Raises Price Target (NASDAQ:ETSY) – Benzinga” on March 11, 2019. More interesting news about Etsy, Inc. (NASDAQ:ETSY) were released by: Nasdaq.com and their article: “3 Top E-Commerce Stocks to Buy Right Now – Nasdaq” published on March 11, 2019 as well as Nasdaq.com‘s news article titled: “Stock Market Today: Home Depot and Etsy Report Sales Gains – Nasdaq” with publication date: February 26, 2019.
Etsy, Inc. operates as a commerce platform to make, sell, and buy goods online and offline worldwide. The company has market cap of $8.46 billion. The Company’s platform includes its markets, services, and technology, which enables to engage a community of sellers and buyers. It has a 116.05 P/E ratio. The firm offers approximately 45 million items across approximately 50 retail categories to buyers.